UNSPSC 51281707: Sarmoxicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R15K9Z4384, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(4-(4-hydroxyphenyl)-2,2-dimethyl-5-oxo-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, methoxymethyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as sarmoxicillin, which bears US NIH Compound Identifier 49808.

UNSPSC 51281707 Sarmoxicillin is a Commodity code that does not align with the recent state and local solicitations indexed under it. The code nominally describes a specific antibiotic pharmaceutical product, yet the recent opportunities posted against this code include naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and a therapeutic pharmacy initiative addressing direct-to-manufacturer prescription programs. None of these solicitations involve sarmoxicillin procurement. The mismatch suggests either a tagging error in the underlying procurement database or that this code is being used as a catch-all for diverse pharmaceutical and medical supply categories. State and local issuers—including county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances—are actively buying pharmaceutical products and medical supplies, but the current indexing under UNSPSC 51281707 does not reliably reflect what is actually being solicited.

Recent activity spans multiple jurisdictions and issuing-body types. Seminole County, Florida posted an IFB (Invitation for Bid 60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: this date predates the posting and likely reflects a data error). The City of Tampa's Purchasing Department solicited medical and first aid supplies for the Tampa Fire Department Rescue Division under Bid 26P00145 (response due March 13, 2026, estimated contract value $700,000), designated as a Small Local Business Enterprise set-aside with a 5 percent bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 (due April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs for a Therapeutic Pharmacy Initiative. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities, including Oregon, with contract effectiveness set for July 1, 2026. Geographic spread includes Florida, Texas, Minnesota, and Oregon, with broader multistate participation through MMCAP.